The cosmetic surgery market has seen considerable growth due to a variety of factors.
• The market size of cosmetic surgery has seen substantial growth in the past few years. The market, which is projected to increase from $53.34 billion in 2024 to $58.62 billion in 2025, implies a Compound Annual Growth Rate (CAGR) of 9.9%.
Factors such as evolving beauty norms, celebrity impact, greater accessibility, the influence of social media, psychological health considerations, as well as media and advertising are driving the growth recorded in the historic period.
The cosmetic surgery market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for significant expansion within the cosmetic surgery market in the next several years. The market is predicted to reach a worth of $79.41 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%.
This anticipated growth during the forecast period can be credited to factors such as the increase in non-invasive procedures, cultural acceptance, aging global population, improved information accessibility, regulatory support and approvals and the rise in male aesthetic procedures. Future trends to look out for during the forecast period consist of technology integration, non-invasive procedures, minimally invasive techniques, the demand for personalized and customizable procedures, utilization of 3D imaging and simulation, as well as the application of regenerative medicine.
The cosmetic surgery market's expansion is anticipated to be fueled by the upsurge in aesthetic treatments. These procedures encompass both surgical and non-surgical methods designed to improve one's physical image. The recent surge in these procedures can be traced back to increased consumer desire for aesthetic improvements, progressive technological advancements, and a heightened consciousness of self-grooming and personal appearance enhancement. Aesthetic procedures simplify and optimize personal looks, thereby spurring self-confidence, encouraging self-care, and effectively addressing specific aesthetic issues. As an example, the British Association of Aesthetic Plastic Surgeons reported a substantial rise in cosmetic surgeries conducted in 2022, with data indicating 31,057 procedures being conducted in the UK that year, a striking 102% increase from the previous year. As the data revealed, women underwent 93% of all the cosmetic surgeries in 2022, a noteworthy increase of 101% compared to 2021. Men, on the other hand, made up 7% of all cosmetic surgeries, marking a significant increase of 118% from the preceding year. Consequently, it's clear that the escalating number of aesthetic procedures will amplify the growth of the cosmetic surgery market.
The cosmetic surgery market covered in this report is segmented –
1) By Procedure Type: Surgical Procedures, Non-Surgical Procedures, Other Procedures
2) By Provider: Spas And Cosmetic Surgery Centers, Hospitals And Specialty Clinics
3) By Gender: Male, Female
4) By Application: Liposuction, Eyelid And Nose Surgery, Body Contouring, Face Reconstruction, Cosmetic Implants, Other Applications
5) By End-User: Hospitals, Surgical Centers, Other End-Users
Subsegments:
1) By Surgical Procedures: Breast Augmentation, Liposuction, Rhinoplasty (Nose Surgery), Facelift Surgery (Rhytidectomy), Eyelid Surgery (Blepharoplasty), Tummy Tuck (Abdominoplasty), Chin And Cheek Surgery, Hair Transplant Surgery, Other Surgical Procedures
2) By Non-Surgical Procedures: Botox Injections, Dermal Fillers (Hyaluronic Acid Fillers), Chemical Peels, Laser Hair Removal, Microdermabrasion, Non-Surgical Facelift (Thread Lift), Cryolipolysis (Fat Freezing), Platelet-Rich Plasma (PRP) Therapy, Other Non-Surgical Procedures
3) By Other Procedures: Body Contouring (CoolSculpting, Radiofrequency), Scalp Micropigmentation, Tattoo Removal, Skin Rejuvenation Treatments (LED Therapy, Microneedling)
The dominant trend emerging in the cosmetic surgery market is product innovation. Major firms within this sector are pinpointing their efforts on the creation of new offerings to bolster their market presence. Merz Aesthetics, for example, a pharmaceutical company based in the U.S., launched a new injectable implant, Radiesse (+) Lidocaine, in February 2022. Radiesse (+) is an injectable dermal filler fashioned out of calcium hydroxylapatite (CaHa) in gel form. This product is crafted to provide volume and structure to lower facial features while concurrently tightening and lifting jowls and buccula and smoothing out and correcting moderate to severe facial wrinkles and folds. Radiesse (+) Lidocaine stands as the first and only aesthetic injectable capable of improving moderate to severe jawline contour loss.
Major companies operating in the cosmetic surgery market include:
• Johnson & Johnson
• Astellas Pharma Inc.
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Medtronic plc
• Polytech Health & Aesthetics GmbH
• AbbVie Inc.
• Daiichi Sankyo Co. Ltd.
• Mylan N.V.
• Bausch Health Companies Inc.
• Eisai R&D Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Ferring Pharmaceuticals plc
• Endo Pharmaceuticals plc
• Galderma SA
• Lumenis Ltd.
• Solta Medical Inc.
• Evolus Inc.
• Revance Therapeutics Inc.
• Syneron Candela Corporation
• Alma Lasers Ltd.
• Sinclair Pharma plc
• HansBiomed Co. Ltd.
• Teoxane Laboratories
• Cynosure Inc.
• Merz Pharma GmbH & Co. KGaA
• Vital Esthetique Inc.
• GC Aesthetics LLC
• Ono Pharmaceutical Co. Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Shionogi & Co. Ltd.
North America was the largest region in the cosmetic surgery market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the cosmetic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.